Cumberland Pharmaceuticals Inc. Total Liabilities and Equity
Cumberland Pharmaceuticals Inc. (CPIX) had Total Liabilities and Equity of $62.88 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2026-08-07
- 2026-06-30: Liabilities and Equity $62.88M.
- 2026-03-31: Liabilities and Equity $71.00M.
- 2025-12-31: Liabilities and Equity $76.82M.
- 2025-09-30: Liabilities and Equity $65.90M.
| Period end | Liabilities and Equity |
|---|---|
| 2026-06-30 | $62.88M 10-Q · filed 2026-08-07 |
| 2026-03-31 | $71.00M 10-Q · filed 2026-05-08 |
| 2025-12-31 | $76.82M 10-Q · filed 2026-08-07 |
| 2025-09-30 | $65.90M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $67.91M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $69.94M 10-Q · filed 2025-05-09 |
| 2024-12-31 | $75.58M 10-K · filed 2026-03-09 |
| 2024-09-30 | $76.75M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $78.52M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $81.51M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $81.78M 10-K · filed 2025-03-07 |
| 2023-09-30 | $87.75M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $89.38M 10-Q · filed 2023-08-11 |
| 2023-03-31 | $89.47M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $92.93M 10-K · filed 2024-03-13 |
| 2022-09-30 | $90.78M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $92.52M 10-Q · filed 2022-08-12 |
| 2022-03-31 | $96.70M 10-Q · filed 2022-05-13 |
| 2021-12-31 | $84.46M 10-K · filed 2023-03-13 |
| 2021-09-30 | $87.57M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $88.85M 10-Q · filed 2021-08-13 |
| 2021-03-31 | $93.35M 10-Q · filed 2021-05-14 |
| 2020-12-31 | $96.46M 10-K · filed 2022-03-11 |
| 2020-09-30 | $96.01M 10-Q · filed 2020-11-13 |
| 2020-06-30 | $97.52M 10-Q · filed 2020-08-14 |
| 2020-03-31 | $97.42M 10-Q · filed 2020-05-22 |
| 2019-12-31 | $104.55M 10-K · filed 2021-03-12 |
| 2019-09-30 | $103.77M 10-Q · filed 2019-11-13 |
| 2019-06-30 | $107.55M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $114.62M 10-Q · filed 2019-05-15 |
| 2018-12-31 | $112.69M 8-K · filed 2020-12-10 |
| 2018-09-30 | $87.43M 10-Q · filed 2018-11-14 |
| 2018-06-30 | $90.44M 10-Q · filed 2018-08-14 |
| 2018-03-31 | $91.09M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $93.23M 10-K · filed 2019-03-12 |
| 2017-09-30 | $90.35M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $87.80M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $91.86M 10-Q · filed 2017-05-15 |
| 2016-12-31 | $93.40M 10-K · filed 2018-03-09 |
| 2016-09-30 | $91.07M 10-Q · filed 2016-11-03 |
| 2016-06-30 | $87.89M 10-Q · filed 2016-08-05 |
| 2016-03-31 | $89.21M 10-Q · filed 2016-05-13 |
| 2015-12-31 | $91.92M 10-K · filed 2017-03-13 |
| 2015-09-30 | $92.06M 10-Q · filed 2015-11-06 |
| 2015-06-30 | $92.92M 10-Q · filed 2015-08-07 |
| 2015-03-31 | $92.19M 10-Q · filed 2015-05-15 |
| 2014-12-31 | $95.41M 10-K · filed 2016-03-14 |
| 2014-09-30 | $93.90M 10-Q · filed 2014-11-07 |
| 2014-06-30 | $93.47M 10-Q · filed 2014-08-08 |
| 2014-03-31 | $91.11M 10-Q · filed 2014-05-12 |
| 2013-12-31 | $87.61M 10-K · filed 2015-03-09 |
| 2013-09-30 | $91.91M 10-Q · filed 2013-11-06 |
| 2013-06-30 | $95.47M 10-Q · filed 2013-08-09 |
| 2013-03-31 | $98.28M 10-Q · filed 2013-05-08 |
| 2012-12-31 | $98.59M 10-K · filed 2014-03-11 |
| 2012-09-30 | $96.93M 10-Q · filed 2012-11-02 |
| 2012-06-30 | $95.38M 10-Q · filed 2012-08-09 |
| 2012-03-31 | $94.57M 10-Q · filed 2012-05-04 |
| 2011-12-31 | $95.52M 10-K · filed 2013-03-12 |
| 2011-09-30 | $96.08M 10-Q · filed 2011-11-07 |
| 2011-06-30 | $94.58M 10-Q · filed 2011-08-08 |
| 2010-12-31 | $92.05M 10-K · filed 2012-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |